Form 4: National Health Investors Director Acquires Shares and Stock Options
SEC Form 4 Filing
Director Robert A. McCabe Jr. reports acquisition of shares through dividend reinvestment and stock options in National Health Investors Inc.
Summary
- Robert A. McCabe Jr., a director of National Health Investors Inc. (NHI), reported changes in beneficial ownership.
- On March 3, 2025, McCabe acquired 10,000 stock options with an exercise price of $73.34, expiring on March 3, 2030.
- McCabe also directly owns 35,274.17 shares of common stock, which includes 1,400.17 shares acquired through the company's Dividend Reinvestment Program in 2024.
- Additionally, McCabe holds 25,000 stock options granted on February 25, 2021, with an exercise price of $69.20, expiring on February 25, 2026.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the director's acquisition of stock options and participation in the dividend reinvestment program, indicating confidence in the company's future performance.
Positives
- Director's participation in the Dividend Reinvestment Program shows confidence in the company's future.
- Acquisition of new stock options suggests a positive outlook on the company's performance.
Future Outlook
The filing does not contain explicit forward-looking statements, but the acquisition of stock options by a director may indicate a positive outlook.
Industry Context
Form 4 filings are routine disclosures, but director's actions can be seen as a signal of confidence or lack thereof in the company's prospects within the healthcare REIT industry.
Comparison to Industry Standards
- Comparing NHI to peers like Welltower (WELL) and Ventas (VTR), director ownership and option grants are common practices.
- The size and terms of the option grants are within typical ranges for executive compensation in the REIT sector.
- Dividend reinvestment programs are also standard, allowing shareholders to increase their stake efficiently.
Stakeholder Impact
- The director's actions could positively influence shareholder sentiment.
- Employees may view the director's investment as a sign of stability and growth potential.
Key Dates
| Date | Description |
|---|---|
| 02/25/2021 | Grant date of 25,000 stock options at $69.20, expiring 02/25/2026 |
| 2024 | Acquisition of 1,400.17 shares through Dividend Reinvestment Program |
| 03/03/2025 | Acquisition of 10,000 stock options at $73.34, expiring 03/03/2030 |
| 03/05/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.